Arena Pharmaceuticals Inc.

(ARNA) Trade

By |

Profile

Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Contact Information

Website: www.arenapharm.com
Email: klind@arenapharm.com
Main Phone: +1 858 453-7200
Address: 6154 Nancy Ridge Drive
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
CEO: Amit D. Munshi
Employees: 159
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 41.09 $ -1.47 (-3.45%)
Last Price 41.09 Change $ -1.47 Change % -3.45 Tick N/A
Bid 40.55 Bid Size 200.00 Ask 44.05 Ask Size 200.00
Open 42.28 High 42.81 Low 40.66 Prev Close 42.56
Last Trade Volume 468,023 52 Wk Hi 50.05 52 Wk Low 29.52
Market Cap 2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,406,452.00 EPS (TTM) -2.68 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 9
Number of Buys 2 3
Number of Sells 3 6
Net Activity 0 6816
Last 10 Buys Shares
Amit D. Munshi 1,000
Randall E. Woods 1,000
Harry F. Hixson 1,000
Donald D. Belcher 1,000
Scott H. Bice 1,000
Christine A. White 1,000
Christine A. White 1,000
Christine A. White 1,000
Last 10 Sell Shares
Steven W. Spector 1,000
Steven W. Spector 1,000
Steven W. Spector 1,000
Christine A. White 1,000
Randall E. Woods 1,000
Steven W. Spector 1,000
Steven W. Spector 1,000
William R. Shanahan 1,000
Jack Lief 1,000
Donald D. Belcher 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 79 79 79 79
Low Target Price Estimate 45 45 45 45
Mean Target Price Estimate 61.5 61 61 61.5
Standard Deviation 9.65 10.31 10.31 9.65
Date of Most Recent Estimate 05/31/18 05/22/18 05/22/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 1 1 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.43 1.43 1.33